Worldwide Clinical trials Austin
Mr Fern joined Worldwide Clinical Trials early phase services in 2007 as Chief Financial Officer, responsible for all financial, human resource and administrative functions. Throughout his tenure at WCT, Mr Fern has been actively involved with all operational and sales aspects of the early phase business.
Keith began his career with Bank of America Securities in Los Angeles. As Vice President of corporate and investment banking, he developed and maintained a $1.5 billion portfolio with Fortune 1000 clients, originating, structuring and executing all capital market and corporate bank loan transactions.
On moving to Austin, Mr Fern took over as Chief Financial Officer for Partnerware Technologies, Inc., a channel management enterprise software company where he raised $41 million in venture capital, acquired and integrated a competitor and helped grow the company from 18 to 102 employees. After serving as CFO at Protier, Inc., another software company, Mr Fern established the Austin office of M&M Trading, a Chicago–based trading firm specializing in yield curve trading (U.S. Treasury Futures) and Eurodollars. At M&M, he was responsible for hiring, training and managing new traders, as well as trading for his own account.
Mr Fern assumed the role of Senior Vice President of Business Development for WCT early phase services in January 2013. Along with Dr. Sherilyn Adcock, he co-manages the day-to-day activities of the sales team. Mr Fern earned his B.S. in History from the University of Texas in 1989 and an M.B.A. from the same institution in 1992.
Stemedica Posts Alzheimer's Stem Cell Data — Drug Discovery & Development
Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer's disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant ..
New partnership brings more personalized cancer treatment to Philadelphia — Phys.Org
"Our participation in the WIN consortium means Jefferson cancer patients will have access to worldwide clinical trials on promising and individualized therapies," says Massimo Cristofanilli, M.D., Director of the Jefferson Breast Care Center. "It ..
Which regulatory bodies control the clinical trials worldwide?
U.S. Food and Drug Administration under the U.S. Department of Health and Human Services controls the clinical trials conduct in United States and to be marketed in the U.S. The European Medicines Agency (EMEA) is a decentralized European agency for the evaluation of medicinal products for marketing authorization in Europe. The Therapeutic Goods Administration or TGA is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. It is a Division of the Australian Department of Health and Ageing. In Japan, National…